Stay updated on Belantamab Mafodotin Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin Combo in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe DREAMM 9 study record now indicates that results are posted, with sections for participant flow, baseline characteristics, outcome measures, and adverse events. A new record version dated 2026-11-06 was added.SummaryDifference0.9%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedThe DREAMM 9 record now lists a second results submission event, indicating additional results-reporting activity. An NIH notice about the transition from “AI” to “SI” also appears.SummaryDifference0.5%

- Check31 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the study record information remains unchanged.SummaryDifference0.1%

- Check38 days agoChange DetectedThe footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry (v3.7.0) has been added to the record history, replacing the previous revision (v3.6.6). This signals an update to the page history, typically reflecting refreshed or corrected content in the study record.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.